Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Multidrug resistance-associated protein (MRP) subfamily transporters facilitate anticancer drug efflux, contributing to cancer cell multidrug resistance.
• Understanding the genetic basis of MRP transporters is crucial for developing effective cancer therapies.

Purpose of the Study:

• To identify the genomic organization of human multidrug resistance-associated protein 7 (MRP7).
• To characterize the promoter region and regulatory elements of the MRP7 gene.
• To investigate the expression and regulation of MRP7 in response to genotoxic agents and HDAC inhibitors.

Main Methods:

• Genomic DNA analysis to determine gene structure (exons and introns).
• Isolation and cloning of the MRP7 promoter region.
• Luciferase reporter assays to measure promoter activity in response to stimuli.
• Western blot analysis to confirm protein expression in transfected cells.

Main Results:

• The human MRP7 gene comprises 22 exons and 21 introns, distinct from other MRP subfamily members.
• A splicing variant, MRP7A, was identified and found to be expressed in most human tissues.
• The MRP7 promoter exhibited significant activity, enhanced by genotoxic agents and trichostatin A in MDCK cells.
• MRP7 protein was localized to the membrane fraction of transfected cells.

Conclusions:

• Human MRP7 possesses a unique genomic structure and a functional promoter region.
• MRP7 expression is inducible by genotoxic stress and histone deacetylase inhibition, suggesting a role in cellular defense mechanisms.
• Further research into MRP7 regulation may offer new strategies for overcoming multidrug resistance in cancer treatment.